E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

BMC Cancer

Saved in:

Bibliographic Details
Main Authors:	Kothandaraman, N., Choolani, M., Bajic, V.B., Brendan, P.N.K., Keow, P.B., Salto-Tellez, M., Huak, C.Y., Razvi, K.
Other Authors:	OBSTETRICS & GYNAECOLOGY
Format:	Article
Published:	2011
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/26076
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.
by: Kothandaraman, N., et al.
Published: (2013)

Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer
by: Zhao, C., et al.
Published: (2011)

In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer
by: Kaur M., et al.
Published: (2018)

Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinumbased chemotherapy
by: Khemmawan Pongsanon, et al.
Published: (2018)

Epithelial ovarian cancer
by: Ng, J.S., et al.
Published: (2016)

SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer
by: Perumal, J., et al.
Published: (2022)

Ovarian Malignant Brenner Tumor
by: Romi Alfianto, -, et al.
Published: (2018)

Malignant ovarian germ-cell tumours
by: Low, J.J.H., et al.
Published: (2016)

Retroperitoneal hematoma masquerading as ovarian malignancy
by: Singh, C., et al.
Published: (2016)

Prognostic factors for survival of epithelial ovarian cancer
by: V. Linasmita, et al.
Published: (2018)

Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer
by: Huang, R.Y.-J., et al.
Published: (2014)

KLK6 as a Predictor of Ovarian Malignancy
by: Primandono Perbowo, et al.
Published: (2019)

Database for exploration of functional context of genes implicated in ovarian cancer
by: Kaur, M., et al.
Published: (2011)

CSIOVDB: A microarray gene expression database of epithelial ovarian cancer subtype
by: Tan, T.Z, et al.
Published: (2020)

Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer
by: Pothacharoen P., et al.
Published: (2014)

Malignant ovarian germ cell tumours: Experience in the National University Hospital of Singapore
by: Lim, F.-K., et al.
Published: (2016)

Identification of Functional Targets in Epithelial Ovarian Carcinoma
by: MIOW QING HAO
Published: (2014)

Detection of recurrence in a surveillance program for epithelial ovarian cancer
by: Suprasert P., et al.
Published: (2014)

Accuracy of frozen section in the diagnosis of malignant ovarian tumor
by: Dittakarn Boriboonhirunsarn, et al.
Published: (2018)

Color Doppler Ultrasonography for Prediction of Malignant Ovarian Tumors
by: Mongkol Benjapibal, et al.
Published: (2018)

Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors
by: Tan, Y., et al.
Published: (2012)

Significant factors predicting malignant upgrading in benign papillary lesions of the breast
by: P. Rushatamukayanunt, et al.
Published: (2020)

IOTA simple rules in differentiating between benign and malignant ovarian tumors
by: Tantipalakorn,C., et al.
Published: (2015)

E-flow doppler indices for prediction of benign and malignant ovarian tumors
by: Tongsong T., et al.
Published: (2014)

Epithelioid, cytokeratin expressing malignant solitary fibrous tumour of the pleura [10]
by: Yan, B., et al.
Published: (2012)

Depot medroxyprogesterone acetate and epithelial ovarian cancer: A multicentre case-control study
by: S. Wilailak, et al.
Published: (2018)

Depot medroxyprogesterone acetate and epithelial ovarian cancer: A multicentre case-control study
by: Wilailak S., et al.
Published: (2017)

Depot medroxyprogesterone acetate and epithelial ovarian cancer: A multicentre case-control study
by: S. Wilailak, et al.
Published: (2018)

Polygenic risk modeling for prediction of epithelial ovarian cancer risk
by: Dareng, Eileen O, et al.
Published: (2023)

The accuracy of intraoperative frozen sections in epithelial ovarian tumor
by: Korrakot Soitong, et al.
Published: (2022)

RUNX3 functions as an oncogene in ovarian cancer
by: Lee, C.W.L., et al.
Published: (2014)

Huge peritoneal malignant mesothelioma mimicking primary ovarian carcinoma
by: Siriwan Tangjitgamol, et al.
Published: (2018)

Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours
by: Tan, Y., et al.
Published: (2012)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin.
by: Sirichaisutdhikorn D., et al.
Published: (2014)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Sirichaisutdhikorn D., et al.
Published: (2014)

RhoA protein expression correlates positively with degree of malignancy in astrocytomas
by: Yan, B., et al.
Published: (2012)

RhoA protein expression correlates positively with degree of malignancy in astrocytomas
by: Yan, B., et al.
Published: (2012)

Survival outcomes of recurrent epithelial ovarian cancer: Experience from a Thailand Northern tertiary care center
by: Jansaka,N., et al.
Published: (2015)

Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline
by: Verna D. Vanderpuye, et al.
Published: (2022)

Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer: Asco resource-stratified guideline
by: Verna D. Vanderpuye, et al.
Published: (2022)